Donanemab 

Phase 3 Results

Leqembi FDA Approval 

New Alzheimer's Drugs - Realistic Expectations

Pipeline: Finger-Prick Alzheimer's Blood Test?

Gut-Brain Health

Volunteering Later in Life Good for Brain

Solanemab for Pre-Clinical Alzheimer's. Phase 3 Data

Community Memory Screening

Opioid Initiation in Dementia Tied to Mortality Risk

Hearing Aids Help Slow Cognitive Decline

Chronic Constipation Linked to Cognitive Decline

Alzheimer's New Diagnostic Guidelines

Pipeline: Alzheimer's Gene-Editing Tools

Alzheimer's Association Statement on Donanemab

NIA-AA Revised Alzheimer's Clinical Guidelines 

Dementia Prevalence in Orange County CA